• 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Overview

With the growing healthcare demands, especially seen in this pandemic, there are currently more vaccine and biotherapeutic manufacturers than before to step up to the crucial requirement of speed, scale and supplies. With variety of bioreactors available in the market for development and manufacture of therapeutics, the major bottleneck to commercialization is the viability of a cell culture process in addressing scale-up and technology transfer.

Process developed on a bench scale bioreactor may meet the productivity and quality criteria, but this may not easily translate into a manufacturing process. This makes it critical to select a predictable, reproducible, robust development and manufacturing scale bioreactor platform. Additionally, a successful scale-up and technology transfer means a good understanding of the engineering aspects of the bioreactors to meet the demand of non-linear scale up parameters.

This webinar outlines the aspects of bioreactor design, characterization and scale-up of a single use stirred tank bioreactor and highlight the benefits that an advanced, flexible control system can bring to bench scale bioreactors; catering to both adherent and suspension cell culture processes.

Guest Speakers

Pankaj Salvi

Senior Bioreactor Applications Scientist,
Pall Corporation

Sateesh Kaginelli

Sr. Scientist Upstream Vaccines R&D,
Reliance Life Sciences

Dr. Ratnesh Jain

Head and Course Coordinator,
Bioprocess Technology, ICT, Mumbai

Who should attend

Designation

CXOs | VPs | Directors | Head | HODs

Research Scientists | Senior Scientists | Principal Scientists

Department

R&D Department

Technology Transfer

Manufacturing

Production

Upstream Processing

What Will You Learn

AGENDA

11.20

REGISTRATION

11.25

WELCOME REMARK BY BLUETECH MEDIA

11.30

Single use Bioreactors and Process optimization challenges

11.50

Digital Twin: Next Generation Bioreactor Control Technology

12.10

Stirred Tank Bioreactor – Benchtop to Manufacturing

12.30
Q&A

12.40

Closing Remarks by BlueTech Media

Copyright @ 2021 bluetech-media.com, All Rights Reserved,
Design & Develope by webtech.ooo